Immunotherapy has been disappointing as a prostate cancer treatment, but a new Columbia study suggests that the powerful treatments have potential when the disease starts to spread.
Dec 12, 2023
0
47
Many Black Americans who are thought to have a high risk of developing kidney disease possess a protective genetic variant that nullifies the extra risk, a new study from Columbia researchers has found. The work is published ...
Dec 11, 2023
0
35
A new study led by researchers at Columbia University indicates that patients who receive methadone take-home doses—a protocol expanded during the COVID pandemic—are no more likely to overdose or drop out of care than ...
Dec 8, 2023
0
0
A novel pilot study that combines mindfulness and exposure intervention shows promise for reducing symptoms of post-traumatic stress in survivors of sudden cardiac arrest (SCA), a leading cause of death in the United States.
Nov 29, 2023
0
4
Colorectal cancer is the second leading cause of cancer death in the United States. It's also one of the most preventable cancers due to the availability of robust screening tools. Yet nearly 40% of Americans opt out of such ...
Nov 20, 2023
0
26
A new study at Columbia University has found that shortening sleep by just 90 minutes for six weeks increased insulin resistance in women who are accustomed to getting adequate sleep. The effect was even more pronounced in ...
Nov 13, 2023
0
1
In the years since a 2005 study found that diabetes patients taking metformin had lower rates of cancer, oncologists have been excited by the prospect of using the inexpensive, safe, and widely used diabetes drug to prevent ...
Nov 6, 2023
0
2
Pancreatic cancer is not just one disease, but that's the way it is currently treated. New work from Tannishtha Reya's lab could help pave the way for a change. The research is published in the journal Cancer Cell.
Nov 6, 2023
0
27
A newly developed prediction model may be able to calculate the risk of opioid relapse among individuals in the early stages of medication treatment—as early as three weeks into therapy.
Nov 3, 2023
0
19
Chemotherapy is essential for many cancer patients, but some suffer from cognitive impairment throughout treatment. "Chemobrain" can consist of deficits in memory, attention, and executive function.
Oct 19, 2023
0
66
